Virax Biolabs Group Limited

VRAX · NASDAQ
Analyze with AI
$0.4059−$0.0041 (−1%)
At close:Dec 16, 2025, 8:59 PM UTC
$0.3999−$0.006 (−1.48%)
After hours:Dec 16, 2025, 9:20 PM UTC
P/E TTM-0.34
P/B TTM0.36
P/S TTM590.22
Dividend Yield0%
EPS-$1.22
Beta1.658
Valuation
PEG Ratio-0.01
FCF Yield-344.18%
EV / EBITDA0.19
More On Valuation »
Quality
ROIC-99.77%
Gross Margin-8,774.51%
Cash Conv. Ratio0.99
More On Quality »
Growth
Revenue 3Y CAGR-9.57%
FCF Growth30.28%
More On Growth »
Safety
Net Debt / EBITDA0.51
Interest Coverage-92.32
More On Safety »
Efficiency
Inventory Turnover4.89
Cash Conv. Cycle21,492.96
More On Efficiency »

Virax Biolabs Group Limited (VRAX) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Virax Biolabs Group Limited (VRAX) stock price today?

As of Dec 16, 2025, 8:59 PM UTC, Virax Biolabs Group Limited (VRAX) stock is trading at $0.4059. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date VRAX stock quotes for informed trading decisions.

What is Virax Biolabs Group Limited's market capitalization?

Virax Biolabs Group Limited (VRAX) has a market capitalization of approximately $1.8M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Virax Biolabs Group Limited's size relative to other companies in the USD market. The market cap figure updates automatically as the VRAX stock price changes.

What is the 52-week range for Virax Biolabs Group Limited stock?

Virax Biolabs Group Limited (VRAX) stock has traded in a 52-week range of $0.35 — $3.20. The 52-week range shows the highest and lowest prices at which VRAX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Virax Biolabs Group Limited stock price to this range provides context for recent price action.

How much trading volume does Virax Biolabs Group Limited stock have?

Virax Biolabs Group Limited (VRAX) stock recently traded approximately 193.1K shares. Trading volume indicates market liquidity and investor interest in VRAX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Virax Biolabs Group Limited stock.

Does Virax Biolabs Group Limited pay dividends to shareholders?

Yes, Virax Biolabs Group Limited (VRAX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Virax Biolabs Group Limited stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Virax Biolabs Group Limited's intraday price range?

Today, Virax Biolabs Group Limited (VRAX) stock has traded in a range of $0.391 — $0.41. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring VRAX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Virax Biolabs Group Limited stock data?

AlphaPilot sources real-time VRAX stock quotes, fundamental financial data, and historical price charts for Virax Biolabs Group Limited from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Virax Biolabs Group Limited stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of VRAX stock performance.